Flare Capital Partners Promotes Vic Lanio to Principal

08:00 EDT 9 Jul 2019 | Businesswire
Flare Capital Partners

Deepens Investment Team to Reinvent the Business of Healthcare

Flare Capital Partners, a leading healthcare technology venture capital firm, today announced the promotion of Vic Lanio to principal.

“Vic has been a tremendous asset to our investment team and has shown a depth of understanding of the healthcare landscape that is impressive,” said Michael Greeley, cofounder and partner, Flare Capital.

“Given the profound investment opportunities as the transformation of our healthcare industry unfolds, Vic will continue to be critical to the success of our Flare Capital portfolio companies and in helping drive new investment opportunities,” added Bill Geary, cofounder and partner.

Vic joined Flare Capital in July 2017 as a Senior Associate, having also been a member of the Flare Scholar Class of 2016. Just prior to joining Flare Capital, Vic was a Product Strategy Manager at naviHealth, responsible for enterprise product strategy during the integration of the legacy naviHealth, Curaspan and RightCare businesses. Vic joined naviHealth by way of Curaspan, where he worked on their successful strategic sale of the company.

David Medvedeff, CEO of Aspen RxHealth, a Flare Capital recent investment, commented “I am very excited about this well-deserved promotion, having worked closely with Vic for the last 18 months and given his important role in Flare Capital’s co-creation of Aspen RxHealth. His depth of understanding of healthcare technology solutions is impressive and been very helpful as we scale the company. He has a terrific network of industry thought leaders which has been a real resource for us.”

Earlier in his career, Vic was a manager at McKinsey & Company serving healthcare providers. He helped build the Objective Health new venture, a tech-enabled consulting model for small to mid-sized health systems that is now a part of McKinsey’s Healthcare practice. Prior to McKinsey, Vic worked at PricewaterhouseCoopers in the Health Industries Advisory Practice, focusing on health system operations, revenue cycle, and personalized medicine.

​Vic obtained his B.S. from Boston College, with majors in Physics and Finance. He also obtained his M.B.A. from the MIT Sloan School of Management.

About Flare Capital Partners

Flare Capital is a team of proven healthcare technology venture capital investors and senior operating executives known for their unparalleled strategic industry resources, insight and total commitment to the success of its entrepreneurs. Flare Capital raised one of the industry’s largest dedicated venture capital funds focused exclusively on early stage opportunities in healthcare technology innovation and is privileged to closely partner with founders and management. Selected investments include Aetion, Aspen RxHealth, Bright Health, Circulation (acquired by LogistiCare), ClearDATA, Curisium, HealthReveal, HealthVerity, higi, Iora Health, Somatus, Valence Health (acquired by Evolent Health), VisitPay and Welltok.

Learn more at and follow the firm on Twitter @FlareCapital

Kim Pegnato
(781) 620-0016


More From BioPortfolio on "Flare Capital Partners Promotes Vic Lanio to Principal"

Quick Search

Relevant Topics

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...